Takeda Pharmaceutical Co stock forecast
Takeda Pharmaceutical Co (0RN3) Share Forecast & Price Target
0RN3 Analyst Ratings
0RN3 Stock 12 Month Forecast
Average Price Target
€39.89▲(13.32% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Shinichiro Muraoka | Morgan Stanley | €35.64→€39.61 | buy | 12.51%Upside | Reiterated | 09/04/26 | ||
| Stephen Barker | Jefferies | €38.47→€40.17 | buy | 14.12%Upside | Reiterated | 08/21/26 | ||
| Koichi Mamegano | Bank of America Securities | €33.95→€38.47 | buy | 9.30%Upside | Reiterated | 08/13/26 | ||
 Unknown AnalystNot Ranked | Goldman Sachs | ― | hold | ― | Reiterated | 08/06/26 | ||
| Miki Sogi | Bernstein | €39.04 | buy | 10.91%Upside | Assigned | 07/07/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Shinichiro MuraokaMorgan Stanley | BuyReiterated€35.64→€39.61 | 09/04/26 | 12.51%Upside | ||
| Stephen BarkerJefferies | BuyReiterated€38.47→€40.17 | 08/21/26 | 14.12%Upside | ||
| Koichi MameganoBank of America Securities | BuyReiterated€33.95→€38.47 | 08/13/26 | 9.30%Upside | ||
| Unknown AnalystGoldman SachsNot Ranked | HoldReiterated | 08/06/26 | ― | ||
| Miki SogiBernstein | BuyAssigned€39.04 | 07/07/26 | 10.91%Upside |
Best Analysts Covering Takeda Pharmaceutical Co
Copying Stephen Barker's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.98% per trade.
Copying Shinichiro Muraoka's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.55% per trade.
Copying Koichi Mamegano's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.06% per trade.
0RN3 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 6 | 6 | 3 | 1 |
| Hold | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 7 | 7 | 4 | 1 |
In the current month, 0RN3 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RN3 average Analyst price target in the past 3 months is 39.89.
0RN3 Financial Forecast
0RN3 Earnings Forecast
Next quarter’s earnings estimate for 0RN3 is EUR 0.25 with a range of EUR 0.23 to EUR 0.27. The previous quarter’s EPS was EUR 0.68. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0RN3 Sales Forecast
Next quarter’s sales forecast for 0RN3 is EUR 6.79B with a range of EUR 6.14B to EUR 7.16B. The previous quarter’s sales results were EUR 6.71B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
